Literature DB >> 9008457

Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography.

V L Roger1, P A Pellikka, M R Bell, C W Chow, K R Bailey, J B Seward.   

Abstract

BACKGROUND: The use of exercise echocardiography for the diagnosis of coronary artery disease (CAD) has been validated in pilot studies but is not documented in clinical practice and in women comparatively with men. The objectives of this study were to determine the effects of sex and of test verification bias on the diagnostic performance of exercise echocardiography. METHODS AND
RESULTS: Three thousand six hundred seventy-nine consecutive patients (1714 women, 1965 men) who underwent an exercise echocardiographic study were studied; the observed sensitivity, specificity, and correct classification rate were calculated among 340 patients (244 men, 96 women) who underwent angiography; to study the effect of test verification bias, sensitivity and specificity were estimated for all patients who underwent exercise echocardiography including those not referred to angiography. In the angiographic group, the prevalence of CAD was 60% in women and 80% in men. The observed sensitivity and specificity of exercise echocardiography was 78% and 44% in men and 79% and 37% in women. After adjustment for test verification bias, the estimated sensitivity was lower in women (32% versus 42% in men), whereas specificity was similar in both sexes. The positive predictive value was lower in women (66%) compared with men (84%).
CONCLUSIONS: In clinical practice, test verification bias results in a lower observed specificity and a higher sensitivity of exercise echocardiography. In women, positive predictive value and adjusted sensitivity are lower compared with that in men.

Entities:  

Mesh:

Year:  1997        PMID: 9008457     DOI: 10.1161/01.cir.95.2.405

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

Review 1.  Myocardial perfusion imaging.

Authors:  R J Gibbons
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

Review 2.  Stress echocardiography in the diagnosis of coronary artery disease.

Authors:  W Mazur; S F Nagueh
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

3.  Anatomy of a meta-analysis: a critical review of "exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance".

Authors:  S M Kymes; D E Bruns; L J Shaw; K N Gillespie; J W Fletcher
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

4.  Exercise-induced left ventricular systolic dysfunction in women heterozygous for dystrophinopathy.

Authors:  Robert M Weiss; Richard E Kerber; Jane K Jones; Carrie M Stephan; Christina J Trout; Paul D Lindower; Kimberly S Staffey; Kevin P Campbell; Katherine D Mathews
Journal:  J Am Soc Echocardiogr       Date:  2010-06-19       Impact factor: 5.251

Review 5.  New insights from major prospective cohort studies with cardiac CT.

Authors:  Sumbal A Janjua; Udo Hoffmann
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

6.  Can the ST segment be saved?

Authors:  Michael S Lauer
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

7.  A meta-analytic comparison of echocardiographic stressors.

Authors:  Yoshinori Noguchi; Shizuko Nagata-Kobayashi; James E Stahl; John B Wong
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

8.  Angina pectoris: has the cornerstone of symptomatic coronary artery disease been moved?

Authors:  Renee C Hessian; Rob S B Beanlands
Journal:  Can J Cardiol       Date:  2007-06       Impact factor: 5.223

9.  First-line testing.

Authors:  A E Iskandrian
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

Review 10.  Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging.

Authors:  A E Iskandrian; J Heo; N Nallamothu
Journal:  J Nucl Cardiol       Date:  1997 Jul-Aug       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.